Canada Expects 168,000 Doses Of Moderna Vaccine As Stronger Variants Of Coronavirus Are Discovered
Right after the British government’s announcement of the discovery of a new COVID-19 variant that boasts a 70% higher spreading rate than its common form in London, England, our Prime Minister Justin Trudeau brought comforting news on Tuesday, December 15th that the pre-ordered 168,000 doses of two-dose Moderna vaccine will be available in Canada by the end of the month, should it clears the necessary regulatory approvals.
With recent polls showing that a sizeable number of Canadians will refuse a vaccine altogether, or will wait some time before lining up for a shot, Trudeau said he wants Canadians to be assured that the science will not be rushed and Canada’s regulators will only approve a product that works. And since the Moderna vaccine’s safety and efficiency already approved by the United States’ Food and Drug Administration, its approval from our own regulators could be expected very soon.
On the contrary to Pfizer’s vaccine that requires a -70°C to -80°C interval for preservation, Moderna’s vaccine can be preserved under temperature as high as -15°C, making its transportation and storage much easier to manage. With a final 94.1% success rate of protecting against COVID-19 and a 100% chance to prevent severe cases of the disease, this Moderna’s two-dose vaccine might just be the better alternative we Canadians so direly need.